
Opinion|Videos|January 31, 2025
GOLD 2025 Report: Addressing Heart Disease in COPD
Panelists discuss how the coexistence of heart disease and chronic obstructive pulmonary disease (COPD) requires careful management as these conditions significantly impact each other. In stable COPD, cardiovascular complications are a leading cause of mortality, whereas acute exacerbations can worsen heart function. Key treatable traits in COPD-associated pulmonary hypertension include hypoxemia, inflammation, and right ventricular dysfunction. Management focuses on optimizing respiratory and cardiac function through appropriate medication selection, oxygen therapy when indicated, and careful monitoring of both conditions to prevent deterioration.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- Why is appropriate treatment of heart disease important in COPD? What are key considerations regarding those with stable COPD and those with acute exacerbations?
- What are some of the “treatable traits” associated with pulmonary hypertension in COPD, and how should patients be treated?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on HCPLive
1
TL1A Antibody Duvakitug Boosts Clinical Remission in UC, Response in CD
2
Survey Shows Peptide Misinformation, Misuse Rising in US
3
Millions of New Patients Eligible for Statins Under 2026 AHA/ACC Guidelines
4
The HCPFive: Top News for Healthcare Providers from the Week of 07/12
5












































































